Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy-Reference-Cited by-同舟云学术

Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy

Published:2018-02 Issue:3 Volume:19 Page:167-170
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Stevenson James M¹

Affiliation:

1. Department of Pharmacy & Therapeutics, University of Pittsburgh, School of Pharmacy, 335 Sutherland Drive, 209 Salk Pavilion, Pittsburgh, PA 15261, USA

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2017-0196

Reference15 articles.

1. Pratt LA, Brody DJ, Gu Q. Antidepressant use among persons aged 12 and over: United States, 2011–2014. NCHS data brief, no 283 (2017). www.cdc.gov/nchs/products/databriefs/db283.htm.

2. Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants

3. SLC6A4 variation and citalopram response

4. Association Between a Functional Serotonin Transporter Promoter Polymorphism and Citalopram Treatment in Adult Outpatients With Major Depression

5. Analysis of Association Between the Serotonin Transporter and Antidepressant Response in a Large Clinical Sample

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in the Diagnosis and Prediction of Medication Response in Depression and the Role of Nutraceuticals;International Journal of Molecular Sciences;2024-07-22

2. Antidepressant and anxiolytic potential of Citrus reticulata Blanco essential oil: a network pharmacology and animal model study;Frontiers in Pharmacology;2024-03-19

3. The pharmacogenomics of selective serotonin reuptake inhibitors;Pharmacogenomics;2022-07

4. Constitutive Serotonin Tone Modulates Molecular and Behavioral Response to Chronic Fluoxetine Treatment: A Study on Genetic Rat Model;Frontiers in Psychiatry;2021-10-01

5. Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics;Pharmacogenomics;2021-06